JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
Lattice Semiconductor
LSCC
$18.3B
| $1.57M | ﹤0.01% |
271,167
-579,656
| -68% | -$3.4M |
2016 Q4
4 quarters
|
|
|
TUP
3302
CALL
DELISTED
Tupperware Brands Corporation
TUP
| $1.57M | ﹤0.01% |
+25,000
| New | +$1.53M |
2017 Q4
0 quarters
|
|
|
TUP
3303
PUT
DELISTED
Tupperware Brands Corporation
TUP
| $1.57M | ﹤0.01% |
+25,000
| New | +$1.53M |
2017 Q4
0 quarters
|
|
|
HTO
3304
H2O America
HTO
$2.52B
| $1.57M | ﹤0.01% |
24,539
-16,809
| -41% | -$1.06M |
2016 Q4
4 quarters
|
|
|
RDC
3305
CALL
DELISTED
Rowan Companies Plc
RDC
| $1.57M | ﹤0.01% |
+100,000
| New | +$1.41M |
2017 Q4
0 quarters
|
|
3306
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.32B
| $1.56M | ﹤0.01% |
28,641
-267
| -0.9% | -$14.1K |
2013 Q4
16 quarters
|
|
3307
Sunrun
RUN
$1.84B
| $1.56M | ﹤0.01% |
265,080
+161,680
| +156% | +$929K |
2016 Q2
6 quarters
|
|
3308
iShares US Financial Services ETF
IYG
$2.08B
| $1.56M | ﹤0.01% |
35,838
+2,745
| +8% | +$114K |
2016 Q1
7 quarters
|
|
3309
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.95B
| $1.56M | ﹤0.01% |
21,630
+2,367
| +12% | +$171K |
2013 Q2
18 quarters
|
|
3310
PUT
APA Corp
APA
$15.2B
| $1.55M | ﹤0.01% |
36,800
-2,900
| -7% | -$122K |
2017 Q2
2 quarters
|
|
3311
CALL
Colgate-Palmolive
CL
$67.4B
| $1.55M | ﹤0.01% |
20,600
+18,600
| +930% | +$1.36M |
2016 Q3
5 quarters
|
|
3312
CEVA Inc
CEVA
$1B
| $1.55M | ﹤0.01% |
33,648
-385
| -1% | -$17.7K |
2016 Q3
5 quarters
|
|
3313
CALL
Regenxbio
RGNX
$490M
| $1.55M | ﹤0.01% |
+46,700
| New | +$1.41M |
2017 Q4
0 quarters
|
|
|
QVCGA
3314
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $1.55M | ﹤0.01% |
+1,310
| New | +$1.52M |
2017 Q4
0 quarters
|
|
|
NTRI
3315
DELISTED
NutriSystem, Inc.
NTRI
| $1.55M | ﹤0.01% |
29,452
+7,934
| +37% | +$417K |
2014 Q4
12 quarters
|
|
|
NIHD
3316
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $1.55M | ﹤0.01% |
3,648,350
-77,871
| -2% | -$29.5K |
2015 Q3
9 quarters
|
|
3317
BlackRock Municipal 2030 Target Term Trust
BTT
$1.4B
| $1.54M | ﹤0.01% |
69,136
-4,341
| -6% | -$97.6K |
2015 Q2
10 quarters
|
|
3318
TETRA Technologies
TTI
$863M
| $1.54M | ﹤0.01% |
361,864
+155,764
| +76% | +$537K |
2016 Q4
4 quarters
|
|
3319
Twilio
TWLO
$46.3B
| $1.54M | ﹤0.01% |
65,425
-147,220
| -69% | -$4.13M |
2016 Q2
6 quarters
|
|
3320
SSR Mining
SSRM
$6.81B
| $1.54M | ﹤0.01% |
175,370
-448,084
| -72% | -$4.13M |
2017 Q3
1 quarter
|
|
3321
Haverty Furniture Companies
HVT
$428M
| $1.54M | ﹤0.01% |
67,850
+29,390
| +76% | +$708K |
2013 Q2
18 quarters
|
|
3322
Towne Bank
TOWN
$3.32B
| $1.53M | ﹤0.01% |
49,905
+11,103
| +29% | +$370K |
2015 Q4
8 quarters
|
|
|
CALY
3323
Callaway Golf Company
CALY
$2.56B
| $1.53M | ﹤0.01% |
109,891
-319,850
| -74% | -$4.58M |
2014 Q4
12 quarters
|
|
3324
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.54B
| $1.53M | ﹤0.01% |
30,150
-1,467
| -5% | -$75.5K |
2013 Q2
18 quarters
|
|
3325
TIM SA
TIMB
$8.29B
| $1.53M | ﹤0.01% |
79,023
+78,791
| +33,962% | +$1.46M |
2017 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.